Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›
Research›
Non-Profits›
Fox Chase Cancer Center
AddedFeb 17, 2024
UpdatedJun 28, 2026
Fox Chase Cancer Center

Fox Chase Cancer Center

Operating

US-based research hospital dedicated to pioneering cancer prevention and providing compassionate care.

Founded
1904
Location
Philadelphia, PA, US
Overview
Compare
Employees
Website

Fox Chase Cancer Center, located in Philadelphia, Pennsylvania, was originally known as the American Oncologic Hospital. It is a non-profit research hospital affiliated with Temple University School of Medicine and Temple University. The center's core mission is to prevail over cancer through bold scientific discovery, pioneering prevention, and compassionate care. As an NCI-designated Comprehensive Cancer Center, Fox Chase specializes in oncology and offers a range of services including cancer research and teaching.

Notable affiliated individuals include Drs. Charnita Zeigler-Johnson and Kevin Henry, who focus on addressing cancer disparities in vulnerable communities. The center is part of the Temple University Health System and has received significant support from donors like Wawa through matching gift challenges. Fox Chase's achievements include groundbreaking research and advancements in cancer treatment, significantly impacting both local and broader communities by improving cancer diagnosis, treatment, and outcomes.

Fox Chase Cancer Center - Quick Facts

When was Fox Chase Cancer Center founded?

Fox Chase Cancer Center was founded in 1904.

Where is Fox Chase Cancer Center's headquarters located?

Fox Chase Cancer Center's headquarters is located in Philadelphia, PA, US.

How many employees does Fox Chase Cancer Center have?

Fox Chase Cancer Center has 1,001 employees as of Feb 10, 2024.

Fox Chase Cancer Center - Classification

Ownership
  • Non-profit
Technology
  • Biotech
Geographic Exposure
  • United States
Customer
  • Enterprise
  • Non-Profit
Main Product
  • Cancer Research
Tags
  • Consulting
  • Healthtech
NAICS
  • 813000Religious, Grantmaking, Civic, Professional, and Similar Organizations
  • 813200Grantmaking and Giving Services
  • 813210Grantmaking and Giving Services
  • 813212Voluntary Health Organizations
  • 810000Other Services (except Public Administration)
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
ISIC
  • 9499Activities of other membership organizations n.e.c.
Show 14 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621400Outpatient Care Centers
  • 621490Other Outpatient Care Centers
  • 621491HMO Medical Centers
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 620000Health Care and Social Assistance
SIC
  • 8010Offices And Clinics Of Doctors Of Medicine
  • 8011Offices And Clinics Of Doctors Of Medicine
  • 8060Hospitals
  • 8390Social Services, Not Elsewhere Classified
  • 8300Social Services
  • 8399Social Services, Not Elsewhere Classified